Baxter Immunoglobulin Fails to Aid Alzheimer’s Patients

Tanning Beds Should Carry Skin Cancer Warnings, FDA Says

Pfizer Begins Selling Viagra Online to Battle Fake Drugs

FDA Warns Shorter Name of New Roche Cancer Drug May Cause Confusion

Unmeltable, Uncrushable: The Holy Grail in Painkillers

J&J Recalls All Bottles of Children’s Tylenol in South Korea

FDA Approves Merck Combination Cholesterol Lowering Pill

FDA Panel Votes Against Aveo’s Kidney Cancer Drug

Drugs from Amgen, Others Assessed by FDA as Radiation Treatments

Ask Well: Long-Term Risk of Antidepressants

Genomic Mutation Studies Unlock Details on Cancers

Caffeinated Snacks Draw FDA Scrutiny

Guilty Plea Expected In Fake-Drugs Case

Mayo Clinic’s Upmarket Move

Glaxo in Drug-Discovery Deal

U.S. Accuses Novartis of Providing Kickbacks

Bristol-Myers Oral Hepatitis C Regimen Looks Competitive: Study

Galapagos Says Discovers Breast Cancer Drug Candidate

Drug Makers Use Safety Rule to Block Generics

FDA Can Be More Aggressive With Pharmacies, Hamburg Says

High Court Justices Seek Compromise in Gene-Patent Case

FDA Seeks More Data on Sarepta Muscular Dystrophy Drug

FDA Declines to Approve New Allergan Migraine Drug

Lilly Reports Positive Results from Two Trials of Diabetes Drug

Bristol-Myers to Spend $250 million to Expand Biologics Facility

GSK Plans $1 million Prize to Jump-start “Electroceuticals”

Biotech Industry at Stake in Human Gene Patent Decision

Acadia Gets Expedited FDA Review Path for Lead Drug

Pharma Reps Aren’t Talking About Drug Risks, Study Finds

For Doctors, Fewer Perks and Free Lunches

Roche to Use Isis’s Technology to Develop Brain Disorder Drug

Pharma Company Resverlogix to Spin Off Unit

FDA Advisers say Bausch & Lomb Implantable Lens Safe, Effective

Orphan Drug Prices Under Siege in Austerity-Minded Europe

Adults Skipping Medicines to Save Money, Research Finds

FDA Approves Return of Drug for Morning Sickness

Multiple Sclerosis Balloon Therapy Fails in Study

Exclusive – Pfizer, Novartis, Abbott Weigh Bids for Brazil’s Ache – sources

New-look Sarepta Eyes Approval for Muscular Dystrophy Drug

AstraZeneca Suffers Fresh Drug Patent Setback in U.S.

FDA Approves Johnson & Johnson Diabetes Drug, canagliflozin

AstraZeneca May Appeal U.S. Patent Ruling on Pulmicourt

J&J Recalls 1.9 Million Blood Sugar Meters After Death

Drugmaker ‘Pay for Delay’ Accords Questioned by Top Court

Phytopharm Gives Up After Parkinson’s Drug Failure

Lundbeck to Develop, Sell Alzheimer’s Drug with Otsuka

Inspection Yields Another Compound Pharmacy Recall

FDA Delays Approval of GSK Bird Flu Vaccine

Biogen’s Tecfidera MS Drug Wins EU Agency’s Backing

Analysis: J&J’s Answer to Botox May Escalate War on Wrinkles

Medical Device Maker Cytori Loses Approval Fight

FDA Advisers Vote for Approval of Abbott’s Implantable Heart Device

AstraZeneca Makes Further Job Cuts

Parental Study Shows Rise in Autism Spectrum Cases

Incyte Falls After Patient Develops Infection

Alzheimer’s Kills More in U.S. as Advocates Seek Funding

Biogen Receives Patent Until 2028 for Multiple Sclerosis Drug Tecfidera

Top Court to Hear Arguments Over Generic Drugmaker Liability

Despite Evidence, Parents’ Fears of HPV Vaccine Grow

Setback for Abbott’s Mitraclip Heart Device